A case of septic salmonellosis with damage to the central nervous system in hiv-infected patient


DOI: https://dx.doi.org/10.18565/epidem.2023.13.4.87-92

Kapustin D.V., Krasnova E.I., Khokhlova N.I., Demchenko S.V., Shishkova O.M., Kriklivaya N.P., Nalimova T.M., Gashnikova N.M., Pozdnyakova L.L.

1) Novosibirsk State Medical University, Novosibirsk, Russia; 2) City Infectious Diseases Clinical Hospital № 1, Novosibirsk, Russia; 3) State Scientific Center for Virology and Biotechnology «Vector» of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Koltsovo, Russia
Objective. Analysis of a case of septic salmonellosis with damage to the central nervous system in a HIV infected patient.
Materials and methods. The data of clinical, laboratory and instrumental diagnostic methods in HIV-infected patient with a septic salmonellosis, who was being treated at the City Infectious Diseases Clinical Hospital № 1 in Novosibirsk, were analyzed.
Results. The clinical course of salmonellosis against the background of severe immunodeficiency was characterized by a rapid transition from the gastrointestinal to the septic form with the development of damage to the central nervous system on the 5th day of hospitalization. The choice of antibacterial therapy tactics was complicated by the presence of resistance of blood-isolated S. enteritidis to ciprofloxacin and amikacin. Despite the resumption of antiretroviral therapy and ongoing antibacterial (taking into account sensitivity) and pathogenetic therapy, the patient’s condition could not be stabilized. Irreversible damage by S. enteritidis to the central nervous system and kidneys against the background of severe immunodeficiency led to severe impairment of vital functions followed by death.
Conclusion. When diagnosing salmonellosis in patients with HIV infection, awareness in terms of the high risk of developing generalized forms of the disease is necessary. In real clinical practice, a study of the drug resistance profile of Salmonella is required to select effective antibacterial therapy.

Literature


1. Сальмонеллез у взрослых: Клинические рекомендации. Клинические рекомендации. М.: Министерство здравоохранения Российской Федерации, 2021. https://legalacts.ru/doc/klinicheskie-rekomendatsii-salmonellez-u-vzroslykh-utv-minzdravom-rossii/


(Salmonellosis in adults: National clinical guidelines). Moscow: Ministry of Health of the Russian Federation, 2021. (In Russ.). https://legalacts.ru/doc/klinicheskie-rekomendatsii-salmonellez-u-vzroslykh-utv-minzdravom-rossii/


2. Centers for Disease Control and Prevention. Multistate Outbreak of Salmonella Tennessee Infections Linked to Peanut Butter (Final Update). https://www.cdc.gov/salmonella/2007/peanut-butter-3-7-2007.html


3. Miller S.I., Pegues D.A. Salmonella species, including Salmonella typhi. In: Mandell G.L., Bennett J.E., Dolin R. eds. Principles and Practice of Infectious Diseases. 9th ed. Philadelphia: Churchill Livingstone, 2010: 2887–903,


4. Mendes M.M., Carminatti M., Pinheiro H.S. Severe sepsis from a Ciprofloxacin resistant salmonellosis in a kidney transplant recipient. J. Bras. Nefrol. 2017; 39(1): 82–5. doi: 10.5935/0101-2800.20170014


5. Bay C., Jofré M., Kuzmanic D., Aguirre C., Gutiérrez V. Meningitis por Salmonella Enteritidis en un lactante. Comunicación de un caso y revisión de la literatura (Salmonella Enteritidis meningitis in an infant. Case report and literature review). Rev. Chilena Infectol. 2020; 37(4): 470–6. doi: 10.4067/S0716-10182020000400470. PMID: 3339966


6. Piggott D.A., Carroll K.C., Lim M., Melia M.T. Nontyphoidal Salmonellosis, Human Immunodeficiency Virus Infection, and Ischemic Stroke. Open Forum Infect. Dis. 2016; 3(2): ofw104. doi: 10.1093/ofid/ofw104


7. Инфекционные болезни: национальное руководство. 3-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2021. 1104 с. DOI: 10.33029/9704-6122-8-INB-2021-1-1104


(Infectious diseases: National Guidelines). 3th ed. Moscow: GEOTAR-Media, 2021. 1104 р. (In Russ.) DOI: 10.33029/9704-6122-8-INB-2021-1-1104.


8. ВИЧ-инфекция у взрослых: Клинические рекомендации. М.: Министерство здравоохранения Российской Федерации, 2020. http://rushiv.ru/wp-content/uploads/2022/11/KR79.pdf


(HIV infection in adults: Сlinical guidelines). Moscow: Ministry of Health of the Russian Federation, 2020. (In Russ.). http://rushiv.ru/wp-content/uploads/2022/11/KR79.pdf


9. ВИЧ-инфекция в Российской Федерации на 31 декабря 2021 г.: ФБУН Центральный НИИ эпидемиологии. http://www.hivrussia.info/wp-content/uploads/2022/03/Spravka-VICH-v-Rossii-na-31.12.2021-g..pdf


(VICH-v-Rossii-na-31.12.2021-g). Central Research Institute of Epidemiology. (In Russ.). http://www.hivrussia.info/wp-content/uploads/ 2022/03/Spravka-VICH-v-Rossii-na-31.12.2021-g..pdf


10. Crump J.A., Sjölund-Karlsson M., Gordon M.A., Parry C.M. Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections. Clin. Microbiol. Rev. 2015; 28(4): 901–37. doi: 10.1128/CMR.00002-15


About the Autors


Dmitry V. Kapustin, Cand. Med. Sci., Assistant, Department of Infectious Diseases, Novosibirsk State Medical University, Russia, Novosibirsk. dmitrij_kapustin_1991@inbox.ru; https://orcid.org/ 0000-0002-7060-4710
Professor Elena I. Krasnova, МD, Head, Department of Infectious Diseases, Novosibirsk State Medical University, Novosibirsk, Russia; krasnova-inf@rambler.ru; https://orcid.org/0000-0003-3168-9309
Natalia I. Khokhlova, Cand. Med. Sci., Associate Professor, Associate Professor, Department of Infectious Diseases, Novosibirsk State Medical University, Novosibirsk, Russia, Novosibirsk.talitas@bk.ru; https://orcid.org/0000-0003-4497-3173
Svetlana V. Demchenko, Infectious Disease Doctor, Infectious Disease Doctor, City Infectious Diseases Clinical Hospital № 1, Novosibirsk, Russia; gikb1@yandex.ru
Olga M. Shishkova, Pathologist, City Infectious Diseases Clinical Hospital № 1; Novosibirsk, Russia; gikb1@yandex.ru
Nadezhda P. Kriklivaya, Research Assistant, Department of Retroviruses, State Scientific Center of Virology and Biotechnology «Vector», Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Koltsovo, Novosibirsk Region, Russia; kriklivaya_np@vector.nsc.ru
Tatiana M. Nalimova, Junior Researcher, Department of Retroviruses, Postgraduate Student, State Scientific Center of Virology and Biotechnology «Vector», Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Koltsovo, Novosibirsk Region, Russia; https://orcid.org/0000-0001-8408-0930
Natalya M. Gashnikova, Cand. Med. Sci., Head, Department of Retroviruses, State Scientific Center of Virology and Biotechnology «Vector», Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being Koltsovo, Novosibirsk Region, Russia; ngash@vector.nsc.ru; https://orcid.org/0000-0002-0891-0880
Larisa L. Pozdnyakova, Cand. Med. Sci., Chief Physician, City Infectious Diseases Clinical Hospital № 1, Novosibirsk, Russia; gikb1@yandex.ru


Similar Articles


Бионика Медиа